Patients tend to have a stronger brain response to music the day after receiving psilocybin-assisted therapy, according to new research published in the Journal of Affective Disorders. The stronger response to music was related to how intense the psychedelic experience...
People who use psychedelic drugs for entheogenic purposes tend to also have heightened spiritual development, according to new research published in the Journal of Psychedelic Studies. The new findings provide insight into how entheogenic drug use is related to spirituality...
The psychedelic drug lysergic acid diethylamide (LSD) make people learn faster when receiving feedback and enhances exploratory behavior, according to new research published in Psychological Medicine. The findings could help shed light on the underlying cognitive mechanisms behind the potential...
It is widely known that doing drugs can cause neurological impairments, but it can be difficult to know why. A study published in NeuroImage: Clinical provides evidence that chronic MDMA may not cause white matter lesions that are seen from...
People who use psychedelic substances in an attempt to self-treat their mental health tend to report mild-to-moderate positive outcomes, according to new research published in the Journal of Psychopharmacology. But there were more negative effects reported by these individuals than...
In people with advanced cancer, psychedelic drugs like psilocybin, LSD and MDMA may significantly reduce the severity of depression and anxiety symptoms. Psychedelic sessions might have an advantage over traditional prescription antidepressants for patients with cancer-related depression or anxiety because...
Post-traumatic stress disorder (PTSD) is a mental health condition that can occur following exposure to a traumatic or repeated stressful events. It is commonly experienced by military veterans and first responders. While available treatments may not work for everyone, recent...
Researchers at the University of Tartu in Estonia have developed a virtual reality (VR) experience that seeks to simulate the subjective effects of psychedelic drugs. They hope that replicating psychedelic experiences within VR will produce similar therapeutic benefits to psychedelic-assisted...
Research recently published in Death Studies sheds light on the relationship between increased subjective well-being after psychedelic use and potential reductions in death anxiety. The findings indicate that a reduction in death anxiety was related to how impactful reports of...
A study of a large, nationally representative sample of U.S. adults has revealed that those who reported lifetime use of ecstasy (i.e., using ecstasy at least once in their life) were less likely to report having difficulty dealing with strangers,...
A study of U.S. Special Operations Forces Veterans participating in an ibogaine and 5-MeO-DMT treatment in Mexico showed that participants treated with these psychedelic substances showed a significant reduction in alcohol misuse 1 month after the start of the treatment....
A recent study published in the Journal of Psychopharmacology found that for those who had used psychedelics in the past, even one dose can result in lasting belief changes about the supernatural or non-physical world. Specifically, the findings revealed significant...
A new experiment in Japan showed that when mice are exposed to a chronic social defeat stress condition, they develop a number of adverse health conditions. But these adverse health conditions were absent in mice that were repeatedly injected with...
The practice of "microdosing" appears to result in a decrease in emotional diversity, according to new research published in the Journal of Psychedelic Studies.
The results from the first randomized, double-blind, placebo-controlled study to systematically investigate the effects of psilocybin in cluster headache has been published in the scientific journal Headache. The initial study provides useful information for creating bigger and more conclusive studies...